These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 16982548)

  • 21. Local Control Outcomes Using Stereotactic Body Radiation Therapy for Liver Metastases From Colorectal Cancer.
    Joo JH; Park JH; Kim JC; Yu CS; Lim SB; Park IJ; Kim TW; Hong YS; Kim KP; Yoon SM; Park J; Kim JH
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):876-883. PubMed ID: 29063852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breathing-motion-compensated robotic guided stereotactic body radiation therapy : Patterns of failure analysis.
    Stera S; Balermpas P; Chan MKH; Huttenlocher S; Wurster S; Keller C; Imhoff D; Rades D; Dunst J; Rödel C; Hildebrandt G; Blanck O
    Strahlenther Onkol; 2018 Feb; 194(2):143-155. PubMed ID: 28875297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
    Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE
    J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors affecting local control of hepatic tumors treated by Stereotactic Body Radiation Therapy.
    Dewas S; Bibault JE; Mirabel X; Fumagalli I; Kramar A; Jarraya H; Lacornerie T; Dewas-Vautravers C; Lartigau E
    Radiat Oncol; 2012 Oct; 7():166. PubMed ID: 23050794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial.
    Scorsetti M; Arcangeli S; Tozzi A; Comito T; Alongi F; Navarria P; Mancosu P; Reggiori G; Fogliata A; Torzilli G; Tomatis S; Cozzi L
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):336-42. PubMed ID: 23433800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes of single dose stereotactic radiotherapy for lung metastases.
    Osti MF; Carnevale A; Valeriani M; De Sanctis V; Minniti G; Cortesi E; Martelli M; Maurizi Enrici R
    Clin Lung Cancer; 2013 Nov; 14(6):699-703. PubMed ID: 23886798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Image-guided robotic stereotactic radiosurgery for unresectable liver metastases: preliminary results.
    Ambrosino G; Polistina F; Costantin G; Francescon P; Guglielmi R; Zanco P; Casamassima F; Febbraro A; Gerunda G; Lumachi F
    Anticancer Res; 2009 Aug; 29(8):3381-4. PubMed ID: 19661360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereotactic radiation therapy for liver metastases: factors affecting local control and survival.
    Andratschke NH; Nieder C; Heppt F; Molls M; Zimmermann F
    Radiat Oncol; 2015 Mar; 10():69. PubMed ID: 25889512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases.
    Andratschke N; Parys A; Stadtfeld S; Wurster S; Huttenlocher S; Imhoff D; Yildirim M; Rades D; Rödel CM; Dunst J; Hildebrandt G; Blanck O
    Radiat Oncol; 2016 May; 11():74. PubMed ID: 27236333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel strategy in the treatment of liver metastases - Hepatic resection combined with stereotactic body radiotherapy.
    Ihnát P; Skácelíková E; Vávra P; Jonszta T; Ihnát Rudinská L; Tomášková H
    Asian J Surg; 2020 Sep; 43(9):902-906. PubMed ID: 31911035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local response and impact on survival after local ablation of liver metastases from colorectal carcinoma by computed tomography-guided high-dose-rate brachytherapy.
    Ricke J; Mohnike K; Pech M; Seidensticker M; Rühl R; Wieners G; Gaffke G; Kropf S; Felix R; Wust P
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):479-85. PubMed ID: 20304566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereotactic radiosurgery for intraventricular brain metastases.
    Farnia B; Voong KR; Brown PD; Allen PK; Guha-Thakurta N; Prabhu SS; Rao G; Wang Q; Zhao Z; Mahajan A
    J Neurosurg; 2014 Dec; 121 Suppl():26-34. PubMed ID: 25434934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Image-guided radiation therapy for liver tumors: gastrointestinal histology matters.
    Katsoulakis E; Riaz N; Cannon DM; Goodman K; Spratt DE; Lovelock M; Yamada Y
    Am J Clin Oncol; 2014 Dec; 37(6):561-7. PubMed ID: 23466584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accumulated Delivered Dose Response of Stereotactic Body Radiation Therapy for Liver Metastases.
    Swaminath A; Massey C; Brierley JD; Dinniwell R; Wong R; Kim JJ; Velec M; Brock KK; Dawson LA
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):639-48. PubMed ID: 26461006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gamma knife radiosurgery in the treatment of patients with single and multiple brain metastases from carcinoma of the breast.
    Amendola BE; Wolf AL; Coy SR; Amendola M; Bloch L
    Cancer J; 2000; 6(2):88-92. PubMed ID: 11069225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor response on CT following hypofractionated stereotactic ablative body radiotherapy for small hypervascular hepatocellular carcinoma with cirrhosis.
    Sanuki N; Takeda A; Mizuno T; Oku Y; Eriguchi T; Iwabuchi S; Kunieda E
    AJR Am J Roentgenol; 2013 Dec; 201(6):W812-20. PubMed ID: 24261388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereotactic body radiotherapy (SBRT) with or without surgery for primary and metastatic liver tumors.
    Kirichenko A; Gayou O; Parda D; Kudithipudi V; Tom K; Khan A; Abrams P; Szramowski M; Oliva J; Monga D; Raj M; Thai N
    HPB (Oxford); 2016 Jan; 18(1):88-97. PubMed ID: 26776856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determinants of survival after liver resection for metastatic colorectal carcinoma.
    Parau A; Todor N; Vlad L
    J BUON; 2015; 20(1):68-77. PubMed ID: 25778299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.
    Ben-Josef E; Normolle D; Ensminger WD; Walker S; Tatro D; Ten Haken RK; Knol J; Dawson LA; Pan C; Lawrence TS
    J Clin Oncol; 2005 Dec; 23(34):8739-47. PubMed ID: 16314634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.